The store will not work correctly when cookies are disabled.
7-methyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-amine
ID: ALA4461144
PubChem CID: 121373940
Max Phase: Preclinical
Molecular Formula: C19H29N
Molecular Weight: 271.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1=C(/C=C/C(C)=C/C=C/C=C/CN)C(C)(C)CCC1
Standard InChI: InChI=1S/C19H29N/c1-16(10-7-5-6-8-15-20)12-13-18-17(2)11-9-14-19(18,3)4/h5-8,10,12-13H,9,11,14-15,20H2,1-4H3/b7-5+,8-6+,13-12+,16-10+
Standard InChI Key: GPIUDAUUJCPYIF-JUZDZPBYSA-N
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
5.2829 -7.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9927 -6.6407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6512 -6.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2829 -7.8665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5771 -6.6366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9454 -7.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6985 -7.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3569 -7.0699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8240 -6.6490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2397 -6.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4042 -6.6407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5298 -7.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1100 -7.0576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5771 -8.2710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8755 -7.0493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9927 -8.2751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9774 -5.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1602 -5.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8755 -7.8665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4125 -5.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 6 1 0
4 1 2 0
5 1 1 0
6 10 2 0
7 2 2 0
8 3 1 0
9 13 1 0
10 12 1 0
11 7 1 0
12 9 2 0
13 11 2 0
14 4 1 0
15 5 1 0
16 4 1 0
17 5 1 0
18 5 1 0
19 15 1 0
20 11 1 0
19 14 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.45 | Molecular Weight (Monoisotopic): 271.2300 | AlogP: 5.09 | #Rotatable Bonds: 5 |
Polar Surface Area: 26.02 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 9.64 | CX LogP: 4.34 | CX LogD: 2.16 |
Aromatic Rings: ┄ | Heavy Atoms: 20 | QED Weighted: 0.69 | Np Likeness Score: 2.31 |
References
1. (2017) Compounds and methods of treating ocular disorders, |